HBI 2024 Logo

Tuesday June 11, 2024

How to lead through change


How do you lead an organisation going through an unprecedented level of change, where technology is disrupting at all levels and with huge macroeconomic and environmental uncertainty? How do you drive and motivate people to deliver on your vision and mission in the short, medium and long term? How do you convince them to embrace technology such as AI where some perceive it to be an existential threat to their jobs? And how do you do this across diverse organisational and geographical businesses? This session brings three senior healthcare leaders who share examples of their success and lessons learned in leading through fundamental periods of change.

Speakers include:

Dr Bernd Ohnesorge, President Europe, Middle East & Africa, Siemens Healthineers
Peter Wharton Hood, Chief Executive, Life Healthcare
Dr Aaron Gerber, President, Diversified Business and SVP, Mass General Brigham

Moderated by Lee Murray, Event Director, Healthcare Business International

Speakers


Dr Bernd Ohnesorge
Dr Bernd OhnesorgePresident: Europe, Middle East & AfricaSiemens Healthineers
Peter Wharton-Hood
Peter Wharton-HoodChief ExecutiveLife Healthcare
Dr Aaron Gerber
Dr Aaron GerberPresident, Diversified Business and Senior Vice PresidentMass General Brigham
Lee Murray
Lee MurrayEvent DirectorHBI

Explore more sessions

View the agenda and see how this event will accelerate your business goals.

Explore similar sessions

7:45 amInteractive Workshop

Breakfast Briefing: Design thinking – how to make an impact in innovation, transformation and patient experience

Design thinking is deployed to get to the heart of complex issues, a step-by-step approach involving a lot of listening to ensure that ideas aren’t just creative but are effective...

L.E.K. Consulting
Craig Wills
Craig WillsManaging DirectorHi Mum! Said Dad
Katya Zubareva
Katya ZubarevaPartnerL.E.K. Consulting
Klaus Boehncke
Klaus BoehnckePartnerL.E.K. Consulting
Jacqueline Thompson
Jacqueline ThompsonPartnerL.E.K. Consulting
Read more

Breakfast Briefing: Design thinking – how to make an impact in innovation, transformation and patient experience


Design thinking is deployed to get to the heart of complex issues, a step-by-step approach involving a lot of listening to ensure that ideas aren’t just creative but are effective and practical – ultimately ensuring that they get adopted. For healthcare CxOs, now is the perfect time to deploy the process with the sector adopting technology at breakneck speed ensuring the voices of all stakeholders are heard as new products, services and care delivery models are developed.

Join Craig Wills, CEO of Hi Mum! Said Dad (an L.E.K. company) and L.E.K.’s Katya Zubareva, Klaus Boehncke and Jacqueline Thompson for this breakfast at HBI 2024, sharing case studies into successful projects that followed this approach and demonstrating the concept, based on working with a leading fertility clinic.

Attendees will leave with a better understanding of the process and when and how to deploy design thinking. If you are developing new products and services, looking to enhance patient and clinician experience, solving complex challenges, or looking to drive change this breakfast is a must-attend.

We hope that you can join us for what is sure to be a lively and informative discussion – with complimentary breakfast!

Please register to attend.

L.E.K. Consulting

Speakers


Craig Wills
Craig WillsManaging DirectorHi Mum! Said Dad
Katya Zubareva
Katya ZubarevaPartnerL.E.K. Consulting
Klaus Boehncke
Klaus BoehnckePartnerL.E.K. Consulting
Jacqueline Thompson
Jacqueline ThompsonPartnerL.E.K. Consulting
2:00 pmPlenary

Getting the most out of your data

How are providers assessing and extracting value from their data? How do you best analyse it to improve outcomes and patient experience? And how do you best analyse it to...

Prof Dr Jörg Debatin
Prof Dr Jörg DebatinFounderHonic
Mark Stoesz
Mark StoeszVice President Enterprise Solutions and Partnerships International MarketsGE Healthcare
Michael Schelper
Michael SchelperSenior Vice President, Corporate DevelopmentCaresyntax
Barty Pleydell-Bouverie
Barty Pleydell-BouverieSenior Asset Leader, Healthcare Analytics McKinsey & Company
Read more

Getting the most out of your data


How are providers assessing and extracting value from their data? How do you best analyse it to improve outcomes and patient experience? And how do you best analyse it to optimise workflow and patient throughput? Three case studies demonstrate what is possible and the pitfalls to avoid.

Speakers include:

Prof Dr Jörg Debatin, Founder, Honic
Mark Stoesz, Vice President Enterprise Solutions & Partnerships International, GE Healthcare
Michael Schelper, Senior Vice President, Corporate Development, Caresyntax
Moderated by Barty Pleydell-Bouverie, Senior Asset Leader, Healthcare Analytics, McKinsey & Company

Speakers


Prof Dr Jörg Debatin
Prof Dr Jörg DebatinFounderHonic
Mark Stoesz
Mark StoeszVice President Enterprise Solutions and Partnerships International MarketsGE Healthcare
Michael Schelper
Michael SchelperSenior Vice President, Corporate DevelopmentCaresyntax
Barty Pleydell-Bouverie
Barty Pleydell-BouverieSenior Asset Leader, Healthcare Analytics McKinsey & Company
12:10 pmInnovation

The reawakening of nuclear medicine

Nuclear medicine has long had its place in the diagnosis and treatment of disease, primarily in cardiology and oncology. Today, the nuclear medicine market is at an inflection point, as...

Ian Poburenny
Ian PoburennyDirectorRothschild & Co
Chaitanya Tatineni
Chaitanya TatineniCEO International and Chief M&A OfficerCurium
Nick Burley
Nick BurleyGroup CEOAlliance Medical
Ben Newton
Ben NewtonGlobal Head of OncologyGE Healthcare
Read more

The reawakening of nuclear medicine


Nuclear medicine has long had its place in the diagnosis and treatment of disease, primarily in cardiology and oncology. Today, the nuclear medicine market is at an inflection point, as the rise of theragnostics and the advent of novel products is expected to nearly quadruple the size of the market in the next 10 years from ~$7bn to $25+bn by 2033. The enormous growth in the field is driven by continued radiopharmaceutical funding where 250+ trials are currently being conducted and by trial funding increasing ~45%+ p.a. between 2019 and 2022. This session features perspectives from a provider, radiopharmaceutical group and OEM on how this is accelerating growth, shaping the market and discussing the medium and long-term obstacles.

Moderation and market overview: Ian Poburenny, Director, Rothschild & Co

Speakers include:

Chait Tatineni, CEO International and Chief M&A Officer, Curium
Nick Burley, Group CEO, Alliance Medical
Ben Newton, Global Head of Oncology, GE Healthcare

Speakers


Ian Poburenny
Ian PoburennyDirectorRothschild & Co
Chaitanya Tatineni
Chaitanya TatineniCEO International and Chief M&A OfficerCurium
Nick Burley
Nick BurleyGroup CEOAlliance Medical
Ben Newton
Ben NewtonGlobal Head of OncologyGE Healthcare